Outcome
| Type |
Measure |
Description |
Time frame |
Safety issue |
| Other |
Change in medication adherence in heart failure patients |
Change in medication adherence will be measures using the Medication Adherence Reasons Scale-5 (MARS -5) containing 5 items. |
Post-1 (42 days following baseline, at the end of the intervention), and post-2 (6 months after baseline). |
|
| Other |
Patient satisfaction with using the technology. |
Patient satisfaction with using the technology will be measured by the Post-Study System Usability Questionnaire. Values: 1-7. Higher score mean worse outcome. |
Post-1 (42 days following baseline, at the end of the intervention) |
|
| Primary |
Change in patient confidence in self-management activities. |
Change in the patient's confidence in self-management of heart failure or colon-rectal cancer disease between baseline and post-1 and 2 will be measured by the 6 items questionnaire Self-Efficacy for Managing Chronic Disease". Values: 1-10. A higher score mean a better outcome. |
Baseline (at discharge), post-1 (42 days following baseline, at the end of the intervention), and post-2 (6 months after baseline) |
|
| Primary |
Change in heart failure self-care behavior |
Change in heart failure patients' self-care behavior between baseline and post-1 and 2 will be measured by use of the European Heart Failure Self-care Behavior Scale. Value: 1-5. Higher score mean worse outcome. |
Baseline (at discharge), post-1, (42 days following baseline, at the end of the intervention) and post-2 (6 months after baseline) |
|
| Secondary |
Change in patient experience with treatment and self-management. |
Change in the patient's experience with treatment and self-management of heart failure and colon-rectal cancer between baseline and post-1 and 2 will be measured by the questionnaire "Patient Experience with Treatment and Self-management" with four dimensions of Medical information (Values:1-6); Monitoring health (Values: 1-6); Medications (Values 1- 5); Medical appointments (Values: 1-5). Higher scores means a worse outcome. |
Baseline (at discharge), post-1(42 days following baseline, at the end of the intervention) , and post-2 (6 months after baseline) |
|
| Secondary |
Change in patient experience of health condition and how it affects daily life. |
Change in the patient's Health Related Quality of Life between baseline and post 1 and 2 will be measured with the European Quality of life 5 Dimensions -5 Levels questionnaire. Values: 1-5, were higher scores mean worse outcome, and on a visual analog scale from 0-100, were higher scores mean better outcome. |
Baseline (at discharge), post-1 (42 days following baseline, at the end of the intervention), and post-2 (6 months after baseline) |
|
| Secondary |
Change in patient experience of constructive support from healthcare personnel |
Change in perceived support between baseline and post-1 and 2 will be measured using 12 items on constructive support. Values: 1-5-point. Higher score mean worse outcome. |
Baseline (at discharge), post-1 (42 days following baseline, at the end of the intervention), and post-2 (6 months after baseline) |
|
| Secondary |
Change in patient experience of shared decision-making. |
Change in the patient's experience of shared decision-making between baseline and post-1 and 2 will be measured using the 3 items questionnaire "CollaboRATE" Value: 0-10. Higher score mean better outcome. |
Baseline (at discharge), post-1 (42 days following baseline, at the end of the intervention), and post-2 (6 months after baseline) |
|
| Secondary |
Change in health care utilization |
Change in health care utilization between baseline and post-1 and 2 will be measured using patients' self-reports of number of visits to the primary healthcare service (i.e., General Practitioner, municipal emergency department) and/or the specialist healthcare service (i.e., outpatient clinic). Fewer visits mean better outcome. |
Baseline (at discharge), post-1 (42 days following baseline, at the end of the intervention), and post-2 (6 months after baseline) |
|
| Secondary |
Days alive and out of hospital |
Days alive and out of hospital will be measured by patient's self-report against data from hospital records, and calculated by subtracting number of days spent away from home due to heart failure or colon-rectal cancer related hospitalization from the day of the first reporting in the patient application and the six months following (post 2). |
Post-2 (6 months after baseline) |
|
| Secondary |
Number of 30 days readmission for heart failure or colon-rectal cancer related incidents |
Numbers of 30-days readmission for Heart failure or Colon-rectal cancer related incidents will be collected from the electronic health care record system in the hospital. |
Post-1 (42 days following baseline, at the end of the intervention). |
|
| Secondary |
Number of 90 days readmission for heart failure or colon-rectal cancer related incidents |
Numbers of 30-days readmission for heart failure or colon-rectal cancer related incidents will be collected from the electronic health care record system in the hospital. |
Post-2 (6 months following baseline) |
|
| Secondary |
Number of 12 months readmission for heart failure or colon-rectal cancer related incidents |
Numbers of 12-months readmission for heart failure or colon-rectal cancer related incidents will be collected from the electronic health care record system in the hospital. |
Post-3 (12 months following baseline) |
|
